In my cart

You have no items in your shopping cart.

AZM 475271


Product overview

  • Name
    AZM 475271
  • Short description
    Src tyrosine kinase inhibitor
  • Biological description
    Src tyrosine kinase inhibitor. Shows anti-proliferative, apoptotic, anti-angiogenic, anti-lymphangiogenic and antimetastatic actions against cancer.
  • Biological action
  • Purity
  • Citations


  • Chemical name
  • Molecular Weight
  • Molecular Formula
  • CAS Number

Storing and Using Your Product

  • Storage instructions
    room temperature
  • Solubility overview
    soluble in DMSO (100mM)
  • Important
    This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. Not for human or veterinary use.

References for AZM 475271

  • Inhibition of SRC tyrosine kinase as treatment for human pancreatic cancer growing orthotopically in nude mice.

    Yezhelyev MV et al (2004) Clin Cancer Res 10(23) : 8028-36.
    PubMedID: 15585638
  • Effect of Src kinase inhibition on metastasis and tumor angiogenesis in human pancreatic cancer.

    Ischenko I et al (2007) Angiogenesis 10(3) : 167-82.
    PubMedID: 17486419
  • Src tyrosine kinase inhibition suppresses lymphangiogenesis in vitro and in vivo.

    Ischenko I et al (2010) Curr Cancer Drug Targets 10(5) : 546-53.
    PubMedID: 20370688
Support & Resources

Reviews & Product Guides